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Previous studies suggested endotoxin, derived from the intestine through the
portal blood to the liver, was predominantly metabolized by Kupffer cells. In the
present study, fluorescent-labeled endotoxin injected into the rat portal vein was
demonstrated not only in Kupffer cells but also in hepatocytes. Furthermore a
great amount oflabeled endotoxin was recovered in bile. In the livers ofpatients
with primary biliary cirrhosis (PBC), immunohistochemistry demonstrated sig-
nificant retention ofendotoxin in the biliary epithelial cells, and treatment with
ursodeoxycholic acid significantly reduced the retention in those cells. The
study for detection of apoptosis demonstrated increased rates of apoptosis in
hepatocytes and biliary epithelial cells in PBC liver, and the rate ofapoptosis in
biliary epithelial cells was significantly reduced after treatment with ursodeoxy-
cholic acid. Immunohistochemistry in PBC liver demonstrated significant
reduction of fluorescence intensity for a 7H6 antigen in biliary epithelial cells,
indicating the increased paracellular permeability ofbile ducts, because cellular
immunolocalization of that antigen has been shown to be inversely correlated
with the paracellular permeability of the tight junction. These results suggest
that, in biliary epithelial cells, retention ofendotoxin, increased apoptosis, and
increased permeability oftightjunctions may be involved in the pathogenesis of
PBC.
BILIARY SECRETION OF ENDOTOXIN
Endotoxin, localized in an outer leaflet of Gram-negative bacterial membrane, pro-
duces various actions in liver diseases, such as multi-organ failure, endotoxin shock, and
hepatorenal syndrome. The liver is the major organ metabolizing endotoxin in the portal
blood derived from the intestine. Therefore, several liver diseases including alcoholic liver
disease, fulminant hepatitis, and cholestatic liver disease, are frequently associated with
endotoxemia. Previous studies indicated that Kupffer cells and hepatic macrophages pre-
dominantly participate in clearance ofendotoxin from the sinusoidal blood [1-3]. The pre-
sent study was aimed to clarify the role of hepatocytes in clearance of endotoxin.
Fluorescein isothiocyanate (FITC)-labeled LPSb (25 mg/100 g body weight, Sigma)
was injected into the rat portal vein. Bile was collected from the cannulated common bile
duct. Fluorescence intensity of collected bile was measured by fluorescence spectropho-
tometry. Both FITC-LPS ofpreinjected form and that in bile were analyzed by HPLC. The
livers were removed, fixed in 10 percent formaldehyde, and embedded in paraffin. One
,um thick liver sections were deparaffinized and fluorescence in sections was observed by
a confocal laser scanning microscope (Olympus GB-200).
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Ten min after injection of FITC-LPS, significant fluorescence was detected in bile
and reached its peak at 20 min. Twenty-five percent of injected fluorescence was recov-
ered in bile within 60 min, while less than 5 percent ofinjected fluorescence was recov-
ered in bile after injection ofFITC-albumin. HPLC demonstrated the same retention time
for preinjected FITC-LPS and FITC-LPS recovered from bile at 20 min after injection of
FITC-LPS, suggesting that FITC-LPS is not metabolized in hepatocytes and secreted into
bile. Confocal laser scanning microscopy demonstrated significant fluorescence not only
in Kupffer cells but also in hepatocytes. Fluorescense intensity was higher in periportal
hepatocytes than in porivenous hepatocytes (Figure 1). Colchicine (a microtubule
inhibitor) significantly reduced secretion of FITC-LPS in bile. Pretreatment with
Gadrinium chloride (GdCl3, an inhibitor of macrophage function) prevented uptake of
FITC-LPS into Kupffer cells but not uptake into hepatocytes, and recovery ofFITC-LPS
in bile was not changed.
These findings indicate:
1) LPS is taken up not only by Kupffer cells but also significantly by hepatocytes.
2) An enormous amount ofLPS is secreted into bile
3) LPS is transcellularly transported in hepatocytes depending on microtubules
(probably via tubulo-vesicular pathway).
4) Biliary secretion of endotoxin is independent from its uptake by Kupffer cells.
LPS in sinusoidal blood, therefore, is directly taken up by hepatocytes and secret
ed into bile independent from endotoxin metabolism in Kupffer cells.
Thus, it is suggested that in several liver diseases such as fulminant hepatitis, alco-
holic liver disease, andcholestasis, dysfunction ofhepatocytes in uptake and biliary secre-
tion ofLPS may result in reduced metabolism ofLPS in liver, leading to systemic endo-
toxemia (Figure 2) [4].
_
Figure 1. Confocal laser scanning micrograph of a rat liver 30 min after injection of FITC-
labeled LPS. While bright fluorescence was noted in Kupffer cells (arrow), a significant level was
also seen in hepatocytes. Fluorescence intensity for FITC-LPS was higher in periportal hepatocytes
(fluorescence intensity, Fl = 112) than in perivenular hepatocytes (Fl = 51).




Figure 2. Schematic picture of endotoxin metabolism in the liver. Endotoxin derived from the
colon is taken up by Kupffer cells and hepatocytes that preferentially secrete endotoxin into bile.
PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS
a) Endotoxin localization in PBC liver
Although PBC is characterized by the destruction of intrahepatic bile ducts, neither
pathogenesis nor primary events has been clarified.
We have studied PBC livers immunohistochemically using an anti-LPS antibody (E5,
Pfizer) to investigate the immunolocalization of endotoxin in the patient's liver, since as
we described, large amount ofendotoxin is secreted into bile, and PBC is characterized as
chronic cholestasis.
By confocal laser scanning microscopy, immunofluorescence for LPS was clearly
demonstrated in the biliary epithelial cells (BEC) in PBC. Some immunofluorescence was
also observed in infiltrating cells around bile ducts as well as in hepatocytes. In the livers
ofpatients with viral liver cirrhosis type C and the histologically normal livers, immuno-
fluorescence was faint or absent in BEC. Fluorescence intensity in BEC was measured
using image analyzer software built in the confocal laser scanning microscope.
Fluorescence intensity in BEC was significantly higher in PBC compared with that in liver
cirrhosis and normal control. Second liver biopsy was obtained in 10 PBC patients after
at least 1 year treatment with ursodeoxycholic acid (UDCA). After UDCA treatment,
immunofluorescent intensity for LPS in BEC was significantly reduced.
These results indicated that in PBC endotoxin is retained in BEC, facilitating BEC to
express adhesion molecules, such as ICAM-1, on the plasma membrane. Furthermore,
endotoxin could be released to the portal areas from BEC, leading to the infiltration of
inflammatory cells around bile ducts.
b) Apoptosis ofbiliary epithelial cells in PBC [5]
To assess the involvement ofapoptosis in the pathologic process ofPBC, sections of
PBC livers were processed by the in situ nick-end labeling method using "Apop Tag Plus"
(Oncor, Gaithersburg, MD). In brief, after proteinase K digestion and inactivation of
endogenous peroxidase, liver specimens were incubated in a solution containing terminal
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deoxynucleotidyl transferase and digoxigenin-labeled deoxyuridine triphosphate and
deoxyadenosine triphosphate. Then, the specimens were reacted with peroxidase-labeled
anti-digoxigenin antibody. Color development was performed with 3-3'-diamino-benzi-
dine-tetrahydrochloride solution and then the specimens were counterstained with methyl
green. All BECs and at least 1000 hepatocytes were evaluated in each specimen for DNA
fragmentation. Positive rates for DNA fragmentation in hepatocytes and BEC were calcu-
lated. Liver specimens of the second liver biopsy of 10 PBC patients, liver tissues of 17
chronic viral hepatitis C, and 16 histologically normal liver tissues (controls), were also
analyzed.
In PBC, the frequency of positive cells with DNA fragmentation was significantly
increased in BEC compared with that in normal controls. Regarding hepatocytes, the pos-
itive frequency for DNA fragmentation both in PBC and chronic viral hepatitis was sig-
nificantly higher than that in the normal controls (Table 1). After treatment with UDCA
for at least 18 months, the frequency of BEC positive for DNA fragmentation was signif-
icantly reduced in PBC.
These results indicate that apoptosis is involved in cellular injury of BEC as well as
hepatocytes in PBC. Recently, toxic bile salts have been shown to induce apoptosis in cul-
tured hepatocytes [6], suggesting that intracellular retention ofthe salts may contribute to
hepatocellular apoptosis during cholestasis in PBC. Mechanisms of cholangiocyte apop-
tosis is not fully understood, however, recent in vitro studies have demonstrated Fas and
cytokines, such as TNF-a and IFN-y, could induce cholangiocyte apoptosis [7, 8]. Thus,
agents which prevent the apoptotic events including the activation of caspase proteases,
Fas signaling, and the mitochondria permeability transition may prove clinically useful.
Treatment with UDCA, the most promising drug for PBC, may reduce apoptosis in the
PBC liver, since UDCA can prevent the mitochondria permeability transition [9] and sup-
press IFN-y-induced major histocompatibility complex class II gene expression [10]
c) Increasedparacellularpermeability ofbiliary epithelial cells in PBC.
Recently, many tight junction (TJ) proteins and TJ-associated proteins, such as
occludin, ZO-1, ZO-2, cingulin, and 7H6 antigen, were identified and characterized. 7H6
antigen is a 155 kd TJ-associated protein. Immunofluorescence localization of 7H6 anti-
gen was demonstrated to closely correlate with paracellular permeability [11, 12]. We
have studied 10 PBC livers by immunofluorescence cytochemistry using an anti-7H6 anti-
gen antibody and a laser scanning microscope.
In PBC livers, immunofluorescence for 7H6 antigen was demonstrated to be discon-
tinuous in hepatocytes, and reduced or disappeared in BEC, while it was continuously
localized at the bile canaliculi of hepatocytes as well as BEC in control livers.
Table 1. Positivity for DNA Fragmentation.
Frequencies ofDNA-fragment-positive cells
BECs Hepatocytes
PBC 4.7 ± 1.4 0.13 ±0.03
CH-C 0 ** 0.04±0.01 **
Normal 0 0
Figures are shown as percentage. * p < .05; ** p < .01; ns, not significant.
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Figure 3. Speculative mechanisms ofbile duct injury in primary biliary cirrhosis.
Fluorescence intensity for 7H6 antigen ofBEC in PBC was significantly reduced in PBC
compared with that in controls. These results indicate the TJ in PBC are impaired both in
BEC and hepatocytes, although BEC have been more seriously involved. Paracellular per-
meability of BEC is increased in PBC, leading to allow toxic bile acids or various anti-
gens leak to the periductal area from the lumen of bile ducts. The spillover may promote
infiltration of lymphocytes, macrophage, and plasma cells around bile ducts, and these
cells can secrete various cytokines, including TNF-a, IFN-y, IL-1, and IL-6. These
cytokines further aggravate the bile duct injury in PBC.
Taken all together, these results suggest the following as speculative pathogenesis in
PBC. Stimulated cytokine production by infiltrated lymphocytes and macrophages around
the bile ducts may increase the apoptosis of BEC. Impaired BEC increase paracellular
leakage ofbile constituents containing toxic bile acids and endotoxin into the portal area.
In addition, impaired BEC cannot excrete the intracellular endotoxin absorbed from bile,
promoting the cellular expression ofICAM-1 and major histocompatibility complex class
II, which further accelerates the infiltration of inflammatory cells which attack BEC
(Figure 3).
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